Investigation Report on China Tobramycin Market, 2010-2019
Description
With economic development and the prevalence of computer in work and life, the number of people suffering from eye problems increases by millions each year in China. Therefore, the demand for eye drops to treat infection, inflammation and asthenopia has increased sharply, which boosts the market expansion of relevant drugs. Driven by new drugs, added indications of old drugs and application of drug release technology, ophthalmic drugs have become a category which has attracted much attention.
Tobramycin is a traditional antibiotic whose eye drop and ointment are the most common prescription drugs for the treatment of potential infection or inflammation caused by eye infection. Currently, dozens of enterprises in China are able to produce tobramycin, among which the TOP5 are s.a. Alcon-Couvreur n.v., Sine Pharma, Kangya of Ningxia Pharmaceuticals Co., Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd and Shanghai Harvest Pharmaceutical Co., Ltd who together dominate the market by taking up a share of over 90%.
Tobramycin has begun to stabilize in recent years despite a rapid development ever since its entry into China. According to the statistics of 22 sample hospitals in key cities, the sales value of tobramycin was CNY 20.12 million in 2014 with a year-on-year growth of 3.93% and CAGR during the period of 2010-2014 reached 1.22%. As the incidence of eye disease keeps going up, tobramycin still enjoys a vast market in China. Although s.a. Alcon-Couvreur n.v. took up the largest market share of about 72% for sales value in 2014, local enterprises reported a fast growth in market share due to their increasing emphasis on ophthalmic drugs, which brought about a decline of 4.64% to s.a. Alcon-Couvreur n.v. in 2014. As local enterprises continue to progress, their market share is expected to keep growing in the next few years despite a dominance of imported drug in tobramycin market.
Readers can get at least the following information from this report:
With economic development and the prevalence of computer in work and life, the number of people suffering from eye problems increases by millions each year in China. Therefore, the demand for eye drops to treat infection, inflammation and asthenopia has increased sharply, which boosts the market expansion of relevant drugs. Driven by new drugs, added indications of old drugs and application of drug release technology, ophthalmic drugs have become a category which has attracted much attention.
Tobramycin is a traditional antibiotic whose eye drop and ointment are the most common prescription drugs for the treatment of potential infection or inflammation caused by eye infection. Currently, dozens of enterprises in China are able to produce tobramycin, among which the TOP5 are s.a. Alcon-Couvreur n.v., Sine Pharma, Kangya of Ningxia Pharmaceuticals Co., Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd and Shanghai Harvest Pharmaceutical Co., Ltd who together dominate the market by taking up a share of over 90%.
Tobramycin has begun to stabilize in recent years despite a rapid development ever since its entry into China. According to the statistics of 22 sample hospitals in key cities, the sales value of tobramycin was CNY 20.12 million in 2014 with a year-on-year growth of 3.93% and CAGR during the period of 2010-2014 reached 1.22%. As the incidence of eye disease keeps going up, tobramycin still enjoys a vast market in China. Although s.a. Alcon-Couvreur n.v. took up the largest market share of about 72% for sales value in 2014, local enterprises reported a fast growth in market share due to their increasing emphasis on ophthalmic drugs, which brought about a decline of 4.64% to s.a. Alcon-Couvreur n.v. in 2014. As local enterprises continue to progress, their market share is expected to keep growing in the next few years despite a dominance of imported drug in tobramycin market.
Readers can get at least the following information from this report:
- market size of tobramycin in China
- competitive landscape of tobramycin in Chinese market
- price of tobramycin made by different enterprises in China
- market outlook of tobramycin in China
- manufacturers of ophthalmic drugs
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF TOBRAMYCIN
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF TOBRAMYCIN IN CHINA
2.1 Patent Status and Approval Information of Tobramycin in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF TOBRAMYCIN IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF TOBRAMYCIN IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF TOBRAMYCIN IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF TOBRAMYCIN IN CHINESE HOSPITALS IN 2014
6.1 S.A. Alcon-Couvreur N.V. (Trade Name: Tobrex)
6.2 Sine Pharma (Trade Name: Xintuoming)
6.3 Kangya of Ningxia Pharmaceuticals Co., Ltd
6.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
7 MAJOR MANUFACTURERS OF TOBRAMYCIN IN CHINESE MARKET, 2010-2014
7.1 S.A. Alcon-Couvreur N.V.
7.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
7.3 Kangya of Ningxia Pharmaceuticals Co., Ltd
7.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
7.5 Humanwell Healthcare Group Co., Ltd
8 MARKET OUTLOOK OF TOBRAMYCIN IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Patent Status of Tobramycin in China
Chart Approval Information of Tobramycin in China
Chart Sales Status of Tobramycin in China
Chart Sales Value of Tobramycin in China, 2010-2014
Chart Sales Value of Tobramycin in Some Regions in China, 2010-2014
Chart Sales Volume of Tobramycin in China, 2010-2014
Chart Sales Volume of Tobramycin in Some Regions in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Made by s.a. Alcon-Couvreur n.v. in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Made by Sine Pharma in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Made by Kangya of Ningxia Pharmaceuticals Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Eye Drop in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Eye Ointment in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Injection in China, 2010-2014
Chart Price of Tobramycin Made by s.a. Alcon-Couvreur n.v. in Some Chinese Cities in 2014
Chart Price of Tobramycin Made by Sine Pharma in Some Chinese Cities in 2014
Chart Price of Tobramycin Made by Kangya of Ningxia Pharmaceuticals Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tobramycin Made by Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
COMPANIES MENTIONED
S.A. Alcon-Couvreur N.V.; Shanghai Sine Pharmaceutical Laboratories Co., Ltd.; Kangya of Ningxia Pharmaceuticals Co., Ltd; Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd; Humanwell Healthcare Group Co., Ltd
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF TOBRAMYCIN IN CHINA
2.1 Patent Status and Approval Information of Tobramycin in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF TOBRAMYCIN IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF TOBRAMYCIN IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF TOBRAMYCIN IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF TOBRAMYCIN IN CHINESE HOSPITALS IN 2014
6.1 S.A. Alcon-Couvreur N.V. (Trade Name: Tobrex)
6.2 Sine Pharma (Trade Name: Xintuoming)
6.3 Kangya of Ningxia Pharmaceuticals Co., Ltd
6.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
7 MAJOR MANUFACTURERS OF TOBRAMYCIN IN CHINESE MARKET, 2010-2014
7.1 S.A. Alcon-Couvreur N.V.
7.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
7.3 Kangya of Ningxia Pharmaceuticals Co., Ltd
7.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
7.5 Humanwell Healthcare Group Co., Ltd
8 MARKET OUTLOOK OF TOBRAMYCIN IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Patent Status of Tobramycin in China
Chart Approval Information of Tobramycin in China
Chart Sales Status of Tobramycin in China
Chart Sales Value of Tobramycin in China, 2010-2014
Chart Sales Value of Tobramycin in Some Regions in China, 2010-2014
Chart Sales Volume of Tobramycin in China, 2010-2014
Chart Sales Volume of Tobramycin in Some Regions in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Made by s.a. Alcon-Couvreur n.v. in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Made by Sine Pharma in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Made by Kangya of Ningxia Pharmaceuticals Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Eye Drop in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Eye Ointment in China, 2010-2014
Chart Sales Value and Market Share of Tobramycin Injection in China, 2010-2014
Chart Price of Tobramycin Made by s.a. Alcon-Couvreur n.v. in Some Chinese Cities in 2014
Chart Price of Tobramycin Made by Sine Pharma in Some Chinese Cities in 2014
Chart Price of Tobramycin Made by Kangya of Ningxia Pharmaceuticals Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tobramycin Made by Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
COMPANIES MENTIONED
S.A. Alcon-Couvreur N.V.; Shanghai Sine Pharmaceutical Laboratories Co., Ltd.; Kangya of Ningxia Pharmaceuticals Co., Ltd; Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd; Humanwell Healthcare Group Co., Ltd
